Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01353053|
Recruitment Status : Unknown
Verified May 2010 by Federal University of São Paulo.
Recruitment status was: Recruiting
First Posted : May 12, 2011
Last Update Posted : May 12, 2011
|Condition or disease|
|Disorder of Transplanted Kidney Cytomegalovirus Infections|
|Study Type :||Observational|
|Estimated Enrollment :||82 participants|
|Official Title:||Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection|
|Study Start Date :||July 2010|
Immunosuppression is the same for all patients in the study until the period between the 3rd and 5th weeks, when patients will be randomized to initial regimen and remain or be converted to everolimus tacrolimus.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01353053
|Hospital Israelita Albert Einstein||Recruiting|
|Sao Paulo, SP, Brazil|
|Contact: Lucio Requião Moura 55-11 email@example.com|
|Principal Investigator: Alvaro Pacheco-Silva, Doctor|